Jouke P Bokma1, Michiel M Winter2, Thomas Oosterhof2, Hubert W Vliegen3, Arie P van Dijk4, Mark G Hazekamp5, Dave R Koolbergen5, Maarten Groenink2, Barbara J M Mulder1, Berto J Bouma1. 1. Department of Cardiology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands Interuniversity Cardiology Institute of the Netherlands. 2. Department of Cardiology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands. 3. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. 4. Department of Cardiology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands. 5. Department of Cardiothoracic Surgery, Academic Medical Center Amsterdam, Amsterdam, The Netherlands Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Abstract
OBJECTIVE: Patients with surgically repaired tetralogy of Fallot (rTOF) may develop functional tricuspid regurgitation (TR) due to annulus dilation. Guidelines suggest pulmonary valve replacement (PVR) in patients with rTOF with progressive TR, but data on clinical outcomes are lacking. Our objective was to determine whether TR was predictive for adverse events after PVR. METHODS: In this retrospective, multicenter cohort study, patients with rTOF who had undergone PVR after preoperative echocardiographic assessment of TR grade were included. Preoperative and postoperative imaging data and a composite of adverse clinical events (death, sustained ventricular tachycardia, heart failure, or supraventricular tachycardia) were collected. Multivariate Cox hazards regression analysis was used to determine which factors were predictive for adverse events after PVR. RESULTS: A total of 129 patients (61% men, age at PVR 32.9±10.4 years) were included. The composite endpoint occurred in 39 patients during 8.4±4.2 years of follow-up. In multivariate analysis, severe preoperative TR (HR 2.49, 95% CI 1.11 to 5.52), right ventricular end-systolic volume (HR 1.02/mL/m(2), 95% CI 1.01 to 1.03) and age at PVR (HR 1.07/year, 95% CI 1.04 to 1.09) were predictive for adverse events. Early postoperative TR was not predictive for adverse events (p=0.96). In patients without any risk factor (age >40 years, right ventricular end-systolic volume >90 mL/m(2) or severe TR), 5-year event-free survival was 100% as compared with 61% in patients with two or three risk factors. CONCLUSIONS: In patients with rTOF, severe preoperative TR was predictive for adverse events after PVR. Close surveillance is warranted in these patients irrespective of postoperative TR. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE:Patients with surgically repaired tetralogy of Fallot (rTOF) may develop functional tricuspid regurgitation (TR) due to annulus dilation. Guidelines suggest pulmonary valve replacement (PVR) in patients with rTOF with progressive TR, but data on clinical outcomes are lacking. Our objective was to determine whether TR was predictive for adverse events after PVR. METHODS: In this retrospective, multicenter cohort study, patients with rTOF who had undergone PVR after preoperative echocardiographic assessment of TR grade were included. Preoperative and postoperative imaging data and a composite of adverse clinical events (death, sustained ventricular tachycardia, heart failure, or supraventricular tachycardia) were collected. Multivariate Cox hazards regression analysis was used to determine which factors were predictive for adverse events after PVR. RESULTS: A total of 129 patients (61% men, age at PVR 32.9±10.4 years) were included. The composite endpoint occurred in 39 patients during 8.4±4.2 years of follow-up. In multivariate analysis, severe preoperative TR (HR 2.49, 95% CI 1.11 to 5.52), right ventricular end-systolic volume (HR 1.02/mL/m(2), 95% CI 1.01 to 1.03) and age at PVR (HR 1.07/year, 95% CI 1.04 to 1.09) were predictive for adverse events. Early postoperative TR was not predictive for adverse events (p=0.96). In patients without any risk factor (age >40 years, right ventricular end-systolic volume >90 mL/m(2) or severe TR), 5-year event-free survival was 100% as compared with 61% in patients with two or three risk factors. CONCLUSIONS: In patients with rTOF, severe preoperative TR was predictive for adverse events after PVR. Close surveillance is warranted in these patients irrespective of postoperative TR. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Kimberley Jacobs; Joseph Rigdon; Frandics Chan; Joseph Y Cheng; Marcus T Alley; Shreyas Vasanawala; Shiraz A Maskatia Journal: J Cardiovasc Magn Reson Date: 2020-05-14 Impact factor: 5.364
Authors: Mieke M P Driessen; Marjolijn A Schings; Gertjan Tj Sieswerda; Pieter A Doevendans; Erik H Hulzebos; Marco C Post; Repke J Snijder; Jos J M Westenberg; Arie P J van Dijk; Folkert J Meijboom; Tim Leiner Journal: J Cardiovasc Magn Reson Date: 2018-01-15 Impact factor: 5.364
Authors: Jef Van den Eynde; Connor P Callahan; Mauro Lo Rito; Nabil Hussein; Horacio Carvajal; Alvise Guariento; Arjang Ruhparwar; Alexander Weymann; Werner Budts; Marc Gewillig; Michel Pompeu Sá; Shelby Kutty Journal: J Am Heart Assoc Date: 2021-12-07 Impact factor: 6.106